First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine. (12th July 2016)

• Record Type: Journal Article
• Authors: Sakurai, Kunie; Kurtz, Andreas; Stacey, Glyn; Sheldon, Michael; Fujibuchi, Wataru
• Is Part Of: Stem cells translational medicine. Volume 5:Number 10(2016)
• Page Start: 1345
• Page End: 1361
• Publication Date: 2016-07-12
• Subjects: Stem cells -- Information sharing -- Biological specimen banks -- Standards -- Regenerative medicine -- Quality control; Stem cells -- Periodicals; Regenerative medicine -- Periodicals; Periodicals; 616.0277405
• DOI: 10.5966/sctm.2015-0393
• Languages: English
• ISSNs: 2157-6564

Abstract

Abstract : This study proposes new minimum information guidelines, Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM), for cellular assay data deposition, to promote data exchange and facilitation of practical regenerative medicine. Abstract : : Advances in stem cell research have triggered scores of studies in regenerative medicine in a large number of institutions and companies around the world. However, reproducibility and data exchange among laboratories or cell banks are constrained by the lack of a standardized format for experiments. To enhance information flow in stem cell and derivative cell research, here we propose a minimum information standard to describe cellular assay data to facilitate practical regenerative medicine. Based on the existing Minimum Information About a Cellular Assay, we developed Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM), which allows for the description of advanced cellular experiments with defined taxonomy of human cell types. By using controlled terms, such as ontologies, MIACARM will provide a platform for cellular assay data exchange among cell banks or registries that have been established at more than 20 sites in the world. Significance : Currently, there are more than 20 human cell information storage sites around the world. However, reproducibility and data exchange among different laboratories or cell information providers are usually inadequate or nonexistent because of the lack of a standardized format for experiments. This study, which is the fruit of collaborative work by scientists at stem cell banks and cellular information registries worldwide, including those in the U.S., the U.K., Europe, and Japan, proposes new minimum information guidelines, Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM), for cellular assay data deposition. MIACARM is intended to promote data exchange and facilitation of practical regenerative medicine.